title: Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
abstract: Next to α-synuclein deposition, microglial activation is a prominent pathological feature in the substantia nigra (SN) of Parkinson's disease (PD) patients. Little is known, however, about the different phenotypes of microglia and how they change during disease progression, in the SN or in another brain region, like the hippocampus (HC), which is implicated in dementia and depression, important non-motor symptoms in PD. We studied phenotypes and activation of microglia in the SN and HC of established PD patients (Braak PD stage 4–6), matched controls (Braak PD stage 0) and of incidental Lewy Body disease (iLBD) cases (Braak PD stage 1–3) that are considered a prodromal state of PD. As recent experimental studies suggested that toll-like receptor 2 (TLR2) mediates α-synuclein triggered microglial activation, we also studied whether TLR2 expression is indeed related to pathology in iLBD and PD patients. A clear α-synuclein pathology-related increase in amoeboid microglia was present in the HC and SN in PD. Also, morphologically primed/reactive microglial cells, and a profound increase in microglial TLR2 expression were apparent in iLBD, but not PD, cases, indicative of an early activational response to PD pathology. Moreover, TLR2 was differentially expressed between the SN and HC, consistent with a region-specific pattern of microglial activation. In conclusion, the regional changes in microglial phenotype and TLR2 expression in primed/reactive microglia in the SN and HC of iLBD cases indicate that TLR2 may play a prominent role in the microglial-mediated responses that could be important for PD progression.
authors.forename: Karlijn J
authors.initials: KJ
authors.lastname: Doorn
authors.forename: Tim
authors.initials: T
authors.lastname: Moors
authors.forename: Benjamin
authors.initials: B
authors.lastname: Drukarch
authors.forename: Wilma Dj
authors.initials: WDj
authors.lastname: van de Berg
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Lucassen
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: van Dam
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D006801:Humans; D020961:Lewy Body Disease / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D017628:Microglia / Q000378:metabolism* / Q000473:pathology*; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology*; D010641:Phenotype; D013378:Substantia Nigra / Q000378:metabolism / Q000473:pathology; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D051844:alpha-Synuclein / Q000378:metabolism; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D051195:Toll-Like Receptor 2; D051844:alpha-Synuclein; C081026:CD68 protein, mouse; D000097382:CD68 Molecule; C497605:Snca protein, mouse; C495342:TLR2 protein, human
references.citation: Brain Pathol. 2014 Mar;24(2):152-65
references.pmid: 24033473
references.citation: Neurobiol Aging. 2009 May;30(5):759-68
references.pmid: 17905482
references.citation: PLoS One. 2013 Nov 13;8(11):e79160
references.pmid: 24236103
references.citation: Glia. 2008 Oct;56(13):1438-47
references.pmid: 18551625
references.citation: Glia. 2008 Jun;56(8):888-94
references.pmid: 18338796
references.citation: Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S28-30
references.pmid: 22166446
references.citation: Acta Neuropathol. 2009 Jun;117(6):635-52
references.pmid: 19330340
references.citation: J Neurol Sci. 2010 Feb 15;289(1-2):81-8
references.pmid: 19758601
references.citation: J Neurol. 2002 Oct;249 Suppl 3:III/1-5
references.pmid: 12528692
references.citation: J Neurosci. 2011 Jul 6;31(27):10076-87
references.pmid: 21734300
references.citation: PLoS One. 2013;8(1):e55375
references.pmid: 23383169
references.citation: Nat Commun. 2013;4:1562
references.pmid: 23463005
references.citation: Brain Pathol. 2010 May;20(3):633-9
references.pmid: 20522088
references.citation: Neuropathol Appl Neurobiol. 2013 Feb;39(1):19-34
references.pmid: 23039106
references.citation: Hippocampus. 2013 Aug;23(8):720-8
references.pmid: 23553678
references.citation: Acta Neuropathol. 1997 Jul;94(1):1-5
references.pmid: 9224523
references.citation: Exp Neurol. 2012 Oct;237(2):318-34
references.pmid: 22750327
references.citation: Cell Tissue Res. 2004 Oct;318(1):121-34
references.pmid: 15338272
references.citation: Nat Neurosci. 2007 Nov;10(11):1387-94
references.pmid: 17965659
references.citation: Blood. 1993 Mar 15;81(6):1607-13
references.pmid: 7680921
references.citation: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S87-92
references.pmid: 20083017
references.citation: Trends Neurosci. 1996 Aug;19(8):312-8
references.pmid: 8843599
references.citation: J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):188-94
references.pmid: 21890574
references.citation: J Neural Transm (Vienna). 2014 Feb;121(2):171-81
references.pmid: 23996276
references.citation: Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
references.pmid: 12498954
references.citation: J Immunol. 2008 Nov 15;181(10):7254-62
references.pmid: 18981147
references.citation: Glia. 2010 Feb;58(3):253-63
references.pmid: 19705460
references.citation: Mov Disord. 2008 Mar 15;23(4):474-83
references.pmid: 18044695
references.citation: Neuromolecular Med. 2010 Jun;12(2):149-63
references.pmid: 19830599
references.citation: Trends Immunol. 2004 Dec;25(12):677-86
references.pmid: 15530839
references.citation: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S1-5
references.pmid: 20082965
references.citation: Hippocampus. 2006;16(10):826-33
references.pmid: 16941622
references.citation: Nat Rev Neurol. 2014 Apr;10(4):217-24
references.pmid: 24638131
references.citation: Semin Immunopathol. 2009 Nov;31(4):513-25
references.pmid: 19763574
references.citation: Acta Neuropathol. 2010 Sep;120(3):277-86
references.pmid: 20644946
references.citation: Mediators Inflamm. 2010;2010:
references.pmid: 20706642
references.citation: Nature. 2014 Apr 3;508(7494):88-92
references.pmid: 24572357
references.citation: Prog Neurobiol. 2012 Aug;98(2):222-38
references.pmid: 22732265
references.citation: Neurobiol Aging. 2008 Nov;29(11):1690-701
references.pmid: 17537546
references.citation: Neurology. 2012 Jun 12;78(24):1939-45
references.pmid: 22649213
references.citation: Neurology. 1988 Aug;38(8):1285-91
references.pmid: 3399080
references.citation: J Neuroinflammation. 2014 Jan 21;11:12
references.pmid: 24447857
references.citation: Neurosci Lett. 1994 Oct 24;180(2):147-50
references.pmid: 7700568
references.citation: Glia. 2001 Mar 1;33(3):256-66
references.pmid: 11241743
references.citation: J Neurol. 2008 Sep;255 Suppl 5:18-32
references.pmid: 18787879
references.citation: Front Neurosci. 2011 Jun 29;5:80
references.pmid: 21747756
references.citation: Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S17-20
references.pmid: 22166424
references.citation: J Neurosci. 2002 Mar 1;22(5):1763-71
references.pmid: 11880505
references.citation: Mov Disord. 2001 Jan;16(1):41-6
references.pmid: 11215591
references.citation: Cell Physiol Biochem. 2007;20(6):947-56
references.pmid: 17982277
references.citation: Mov Disord. 2011 Mar;26(4):653-8
references.pmid: 21370256
references.citation: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S200-4
references.pmid: 20082990
references.citation: Exp Gerontol. 2007 Aug;42(8):762-71
references.pmid: 17592750
references.citation: Neuron. 2003 Sep 11;39(6):889-909
references.pmid: 12971891
references.citation: Sci Rep. 2013;3:1393
references.pmid: 23462811
references.citation: Mov Disord. 2009;24 Suppl 2:S748-53
references.pmid: 19877242
references.citation: Trends Neurosci. 2006 Feb;29(2):68-74
references.pmid: 16406093
references.citation: Acta Neuropathol. 2005 Feb;109(2):141-50
references.pmid: 15619128
references.citation: Neuropathol Appl Neurobiol. 2013 Feb;39(1):3-18
references.pmid: 23252647
references.citation: Curr Top Microbiol Immunol. 2009;336:155-68
references.pmid: 19688333
references.citation: FASEB J. 2005 Apr;19(6):533-42
references.pmid: 15791003
references.citation: Immunol Rev. 2009 Jan;227(1):221-33
references.pmid: 19120487
references.citation: Neurobiol Dis. 2006 Feb;21(2):404-12
references.pmid: 16182554